Skip to main content
Article thumbnail
Location of Repository

The utility of B-type natriuretic peptide in predicting postoperative cardiac events and mortality in patients undergoing major emergency non-cardiac surgery

By Brian Cuthbertson, Gemma Card, Bernard L. Croal, Jane McNeilly and Graham Hillis


B-type natriuretic peptide (BNP) levels predict cardiovascular risk in several settings. We hypothesized that they would identify individuals at increased risk of complications and mortality following major emergency non-cardiac surgery.Forty patients were studied with a primary end-point of a new post-operative cardiac event, and/or development of significant ECG changes, and/or cardiac death. The main secondary outcome was all cause mortality at 6 months. Preoperative BNP levels were higher in 11 patients who suffered a new postoperative cardiac event (p=0.001) and predicted this outcome with an area under the receiver operating characteristic curve of 0.85 (CI=0.72-0.98,p=0.001). A pre-operative BNP value > has a sensitivity of 82% and a specificity of 79% for the primary end-point. In this small study, pre-operative BNP levels identify patients undergoing major emergency non-cardiac surgery who are at increased risk of early post-operative cardiac events. Larger studies are required to confirm these data.Peer reviewedPreprin

Topics: B-type natriuretic peptide, non-cardiac surgery, emergency surgery, risk stratification, RD Surgery
Publisher: Blackwell
Year: 2007
DOI identifier: 10.1111/j.1365-2044.2007.05146.x
OAI identifier:

Suggested articles


  1. (1997). A correlation between atrial natriuretic peptide, brain natriuretic peptide, and perioperative cardiac and renal functions in open heart surgery. Journal of the Japanese Association for Thoracic Surgery
  2. (1993). A randomised clinical trial of the effect of deliberate peri operative increase of oxygen delivery on mortality in high risk surgical patients.
  3. (1996). American College of Cardiology/American Heart Association task force report. Guidelines for peri operative cardiovascular evaluation for non cardiac surgery.
  4. (2004). Analytical and clinical evaluation of the Bayer ADIVA Centaur automated B type natriuretic peptide assay in patients with heart failure: a multisite study. Clinical Chemistry
  5. (1999). Annual report
  6. (2005). B type natriuretic peptide and the prediction of outcome in patients admitted to intensive care. Anaesthesia
  7. (1998). Biochemical detection of left ventricular systolic dysfunction. Lancet
  8. (1986). Cardiac assessment for patients undergoing noncardiac surgery. A multifactorial clinical risk index.
  9. (1999). Cardiac troponin I cutoff values to predict postoperative cardiac complications after circulatory arrest and profound hypothermia.
  10. (2004). Committee on Standardization of Markers of Cardiac Damage of the IFCC. Evaluation of Imprecision for Cardiac Troponin Assays at Low Range Concentrations. Clinical Chemistry
  11. (1999). Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation
  12. (1994). Diagnosis of perioperative myocardial infarction with measurement of cardiac troponin I. New England
  13. (2002). European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials.
  14. (1994). Hypoxia stimulates release of ANP and BNP from perfused rat ventricular myocardium.
  15. (2003). Increased B type Natruiretic Peptide (BNP) level is a strong predictor for cardiac dysfunction in intensive care unit patients. Anaesthesia and Intensive Care
  16. (2003). Increased cardiac BNP expression associated with myocardial ischemia.
  17. (2002). Meta analysis of hemodynamic optimization in high risk patients. Critical Care Medicine
  18. (1977). Multifactorial index of cardiac risk in noncardiac surgical procedures.
  19. (1998). Myocardial infarction after noncardiac surgery. Anesthesiology
  20. (1997). Perioperative myocardial cell injury: the role of troponins.
  21. (2004). Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and Death. New England
  22. (2006). Predictive value of plasma brain natriuretic peptide for cardiac outcome after vascular surgery. Heart
  23. (2005). Preoperative plasma N terminal pro brain natriuretic peptide as a marker of cardiac risk in patients undergoing elective non cardiac surgery.
  24. (1997). Prognostic value of cardiac troponin T after noncardiac surgery: 6 month follow up data.
  25. (2002). Reference interval for troponin I on the ACS: Centaur assay: a recommendation based on the recent redefinition of myocardial infarction. Clinical Chemistry
  26. (2003). Scottish Audit of Surgical Mortality. Annual report
  27. (2005). Scottish Hip Fracture Audit Report
  28. (1996). Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension
  29. (2003). The confounding effects of age, gender, serum creatinine, and electrolyte concentrations on plasma B type natriuretic peptide concentrations in critically ill patients. Critical Care Medicine
  30. (1999). The effect of bisoprolol on perioperative mortality and myocardial infarction in high risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. New England
  31. (2001). The prognostic value of B type natriuretic peptide in patients with acute coronary syndromes.
  32. The utility of B type natriuretic peptide in predicting 2 year mortality after major non cardiac surgery. Under final review
  33. (2007). The utility of B type natriuretic peptide in predicting peri operative cardiac events after major non cardiac surgery. Accepted for publication
  34. (1996). Troponin T as a marker for myocardial ischemia in patients undergoing major noncardiac surgery.
  35. (2002). Utility of B Natriuretic Peptide in Detecting Diastolic Dysfunction Comparison With Doppler Velocity Recordings. Circulation
  36. (2005). Utility of B type natriuretic peptide in predicting the level of peri and post operative cardiovascular support required after coronary artery bypass grafting. Critical Care Medicine
  37. (1997). Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.